CELL AND GENE THERAPY MARKET ANALYSIS

Cell therapy is the administration of living cells in patients for the treatment of a disease. The source of cell can be autologous or allogeneic, which can be derived from stem cells such as bone marrow. Stem cells therapy is used in bone marrow transplantation. Gene therapy is the introduction, removal, or change in the patient's genetic code for treatment of a disease. Moreover, it modifies the expression of an individual’s genes or repair abnormal genes. The therapy involves administration of nucleic acid (DNA/RNA) with carriers called as vectors.

Market Dynamics

Increasing prevalence of cancer diseases is a major factor driving the cell and gene therapy market growth. According to the World Cancer Research Funds and the American Institute for Cancer Research, in 2018, there were around 18 million cases of cancer, of which around 9.5 million were in men and around 8.5 million in women, globally. Moreover, introduction of innovative products and rich pipeline of cell and gene therapy is expected to boost the market growth. For instance, around 150 gene therapies are currently in the development stage. Gene replacement accounts for around two third of gene therapy pipeline. However, around 49% of gene therapies are under preclinical and discovery stages. During 2012-18, around 351 gene therapy deals were signed. For instance Gilead’s Kite Pharma received exclusive rights to Sangamo Therapeutics’ zinc finger nuclease gene editing technology, for $3.2bn.

Key features of the study:

This report provides in-depth analysis of the cell and gene therapy market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cell and gene therapy market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Amgen, Biogen, BioMarin Pharmaceuticals, Bristol-Myers Squibb Company, GlaxoSmithKline, Novartis, Pfizer, Regeneron Pharmaceuticals and Sanofi, Spark Therapeutics, Agilis Biotherapeutics, Angionetics AVROBIO, Freeline Therapeutics, Horama, MeiraGTx, Myonexus Therapeutics, Nightstar Therapeutics, Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., and MEDIPOST
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global cell and gene therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cell and gene therapy market

Detailed Segmentation:

Global Cell and Gene Therapy Market, By Therapy Type:

Cell Therapy

Stem Cells
T Cells
Dendritic Cells
NK Cells
Tumor Cells

Gene Therapy

Global Cell and Gene Therapy Market, By Indication:

Cardiovascular Disease
Cancer
Genetic Disorder
Infectious Disease
Neurological Disorders
Others

Global Cell and Gene Therapy Market, By Scale of Operation:

In House
Outsourced

Global Cell and Gene Therapy Market, By Geography:

North America

By Therapy Type:

Cell Therapy

Stem Cells
T Cells
Dendritic Cells
NK Cells
Tumor Cells

Gene Therapy

By Indication:

Cardiovascular Disease
Cancer
Genetic Disorder
Infectious Disease
Neurological Disorders
Others

By Scale of Operation:

In House
Outsourced

By Country:

U.S.
Canada

Latin America

By Therapy Type:

Cell Therapy

Stem Cells
T Cells
Dendritic Cells
NK Cells
Tumor Cells

Gene Therapy

By Indication:

Cardiovascular Disease
Cancer
Genetic Disorder
Infectious Disease
Neurological Disorders
Others

By Scale of Operation:

In House
Outsourced

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

Europe

By Therapy Type:

Cell Therapy

Stem Cells
T Cells
Dendritic Cells
NK Cells
Tumor Cells

Gene Therapy

By Indication:

Cardiovascular Disease
Cancer
Genetic Disorder
Infectious Disease
Neurological Disorders
Others

By Scale of Operation:

In House
Outsourced

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific

By Therapy Type:

Cell Therapy

Stem Cells
T Cells
Dendritic Cells
NK Cells
Tumor Cells

Gene Therapy

By Indication:

Cardiovascular Disease
Cancer
Genetic Disorder
Infectious Disease
Neurological Disorders
Others

By Scale of Operation:

In House
Outsourced

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

By Therapy Type:

Cell Therapy

Stem Cells
T Cells
Dendritic Cells
NK Cells
Tumor Cells

Gene Therapy

By Indication:

Cardiovascular Disease
Cancer
Genetic Disorder
Infectious Disease
Neurological Disorders
Others

By Scale of Operation:

In House
Outsourced

By Country:

GCC
Israel
Rest of Middle East

Africa

By Therapy Type:

Cell Therapy

Stem Cells
T Cells
Dendritic Cells
NK Cells
Tumor Cells

Gene Therapy

By Indication:

Cardiovascular Disease
Cancer
Genetic Disorder
Infectious Disease
Neurological Disorders
Others

By Scale of Operation:

In House
Outsourced

By Country:

South Africa
Central Africa
North Africa

Company Profiles

Amgen *

Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies

Request the sample copy of here:

https://www.coherentmarketinsights.com/insight/request-sample/2475

Download the PDF Brochure here:

https://www.coherentmarketinsights.com/insight/request-pdf/2475

Buy now the market research report here:

https://www.coherentmarketinsights.com/insight/buy-now/2475

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

What we provide:

Customized Market Research Services
Industry Analysis Services
Business Consulting Services
Market Intelligence Services
Long term Engagement Model
Country Specific Analysis

Explore CMI Services here

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: [email protected]

Source:

https://www.coherentmarketinsights.com/market-insight/cell-and-gene-therapy-market-2475